About Labviva
Labviva is a company based in Cambridge (United States) founded in 2017 by Nicholas Rioux, Aaron Miramontes, and Siamak Baharloo.. Labviva has raised $55.75 million across 5 funding rounds from investors including 53 Stations, Biospring and B Capital. The company has 8 employees as of December 31, 2020. Labviva offers products and services including Purchasing Platform, Inventory Management System, and Dashboard & Analytics. Labviva operates in a competitive market with competitors including Cytiva, PerkinElmer, Zageno, Fortis Life Sciences and Leica Biosystems, among others.
- Headquarter Cambridge, United States
- Employees 8 as on 31 Dec, 2020
- Founders Nicholas Rioux, Aaron Miramontes, Siamak Baharloo
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Labviva, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$55.75 M (USD)
in 5 rounds
-
Latest Funding Round
$25 M (USD), Series B
Jan 13, 2025
-
Investors
53 Stations
& 4 more
-
Employee Count
8
as on Dec 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Labviva
Labviva offers a comprehensive portfolio of products and services, including Purchasing Platform, Inventory Management System, and Dashboard & Analytics. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for optimizing life sciences spend and supplier integration.
Automates stock tracking and reduces costs in life sciences operations.
Provides real-time data insights for purchasing and inventory decisions.
Unlock access to complete
Funding Insights of Labviva
Labviva has successfully raised a total of $55.75M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $25 million completed in January 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series B — $25.0M
-
First Round
First Round
(01 May 2019)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2025 | Amount | Series B - Labviva | Valuation | 53 Stations | |
| Mar, 2023 | Amount | Series A - Labviva | Valuation | Biospring Partners | |
| Jun, 2021 | Amount | Seed - Labviva | Valuation | Senator Investment Group |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Labviva
Labviva has secured backing from 5 investors, including venture fund investors. Prominent investors backing the company include 53 Stations, Biospring and B Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage venture capital investments are provided by 53 Stations.
|
Founded Year | Domain | Location | |
|
Biospring is engaged in partnering with pharma services businesses.
|
Founded Year | Domain | Location | |
|
Multistage investments are directed toward technology, healthcare, and climate sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Labviva
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Labviva
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Labviva Comparisons
Competitors of Labviva
Labviva operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cytiva, PerkinElmer, Zageno, Fortis Life Sciences and Leica Biosystems, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Life science software and research products are provided online.
|
|
| domain | founded_year | HQ Location |
Medical instruments and supplies are manufactured and provided for healthcare.
|
|
| domain | founded_year | HQ Location |
Marketplace and life science research community for biotech research kits
|
|
| domain | founded_year | HQ Location |
A trusted partner in life sciences and diagnostics solutions.
|
|
| domain | founded_year | HQ Location |
Provides tools for anatomic pathology, histology, and digital cancer diagnostics worldwide.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Labviva
Frequently Asked Questions about Labviva
When was Labviva founded?
Labviva was founded in 2017 and raised its 1st funding round 2 years after it was founded.
Where is Labviva located?
Labviva is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Who is the current CEO of Labviva?
Siamak Baharloo is the current CEO of Labviva. They have also founded this company.
Is Labviva a funded company?
Labviva is a funded company, having raised a total of $55.75M across 5 funding rounds to date. The company's 1st funding round was a Seed of $8M, raised on May 01, 2019.
How many employees does Labviva have?
As of Dec 31, 2020, the latest employee count at Labviva is 8.
What does Labviva do?
Labviva was founded in 2017 in Cambridge, United States. An AI-powered digital marketplace is maintained to connect researchers with suppliers of reagents, chemicals, and instrumentation within the life sciences sector. Procurement systems are integrated to facilitate transactions. Operations focus on streamlining access to essential lab materials across the industry.
Who are the top competitors of Labviva?
Labviva's top competitors include Cytiva, Zageno and PerkinElmer.
What products or services does Labviva offer?
Labviva offers Purchasing Platform, Inventory Management System, and Dashboard & Analytics.
Who are Labviva's investors?
Labviva has 5 investors. Key investors include 53 Stations, Biospring, B Capital, Glasswing Ventures, and Senator Investment Group.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.